ciprofloxacin has been researched along with Corridor Disease in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lizundia, R | 1 |
| Werling, D | 1 |
| Langsley, G | 1 |
| Ralph, SA | 1 |
1 other study available for ciprofloxacin and Corridor Disease
| Article | Year |
|---|---|
Theileria apicoplast as a target for chemotherapy.
Topics: Animals; Antiprotozoal Agents; Cattle; Drug Delivery Systems; Inhibitory Concentration 50; Models, B | 2009 |